Search for: "Johnson v. Young et al"
Results 21 - 40
of 69
Sorted by Relevance
|
Sort by Date
29 Jul 2018, 4:50 pm
The Guardian has an article considering how social media and the celebrity culture is “harming young people”. [read post]
12 Mar 2012, 8:13 am
In December 1833, the American Monthly Review commented on a newly published book by Joseph Story. [read post]
2 Jul 2008, 4:08 pm
(NFP) NFP criminal opinions today (12): Tomika Johnson v. [read post]
23 Sep 2023, 7:21 pm
AN INTRODUCTION TO E. [read post]
9 Jun 2023, 9:07 am
AN INTRODUCTION TO E. [read post]
12 Jul 2021, 9:01 am
SJ Lofts, LLC et al, 2021 WL 2823073 (E.D. [read post]
25 Jun 2012, 10:39 am
Baker III et al., Football v. [read post]
10 Mar 2008, 1:10 pm
MASON et al. v. [read post]
22 Sep 2008, 6:06 pm
State of Indiana (NFP) Jermaine Young v. [read post]
19 Aug 2015, 11:36 am
Johnson, et al., takes the position that it does not “take much for a plaintiff in a discrimination case to overcome a summary judgment motion. [read post]
10 Dec 2023, 4:59 am
Carly Forrest et al, Lexology: Vicarious Liability in Scotland – the retreat continues: on the recent Inner House judgment in C & S v Shaw and Live Active Leisure [2023] CSIH 36. [read post]
10 Feb 2024, 1:07 am
Baptista et. al. [read post]
9 Aug 2012, 5:00 am
Johnson & Johnson (?) [read post]
10 Sep 2011, 12:59 am
., et al. v. [read post]
12 Jul 2018, 3:30 am
By Wolfmann [CC BY-SA 4.0 ], from Wikimedia Commons Minarsky v. [read post]
12 Jul 2018, 3:30 am
By Wolfmann [CC BY-SA 4.0 ], from Wikimedia Commons Minarsky v. [read post]
7 Nov 2016, 8:44 am
People may wonder about the increased skepticism of young adults to expert opinion and analysis, but I don’t think one has to look much further than unfounded scaremongering by people in positions of authority during their teenage years to see part of the problem. [read post]
18 Apr 2008, 2:00 am
Lélos Kai Sia EE (and Others) v GlaxoSmithKline AEVE: (IPKat), US: Bio commends Sen Specter for patent reform stance: (Patent Docs), US: USPTO rules on two of four neural stem cell patents in dispute between StemCells Inc and Neuralstem Inc; parties disagree on how extensively claims amended: (IP Law360), (IPBiz), US: Insmed continues fight for generic biologic approval: (GenericsWeb), Pharma & Biotech - Products Cipralex (Escitalopram) –… [read post]
31 Aug 2014, 12:49 pm
Young, “Equity,”[2] The New South Wales Bar Association (August 2007). [read post]
19 Dec 2022, 2:31 am
NPR, Al Jazeera and CNN cover the claim. [read post]
